Numerous studies have demonstrated the efficacy of insulin pump use, with and without continuous glucose monitoring (CGM) in individuals with type 1 diabetes (T1D).24–32 However, a growing body of evidence shows similar benefits in individuals with type 2 diabetes (T2D) who are treated with multiple daily insulin injections (MDI).33–44. This evidence concerns the gene INS and type 2 diabetes mellitus.